Magli M C, Gianaroli L, Ferraretti A P, Fortini D, Aicardi G, Montanaro N
SISMER, Reproductive Medicine Unit, Bologna, Italy.
Hum Reprod. 1998 May;13(5):1331-5. doi: 10.1093/humrep/13.5.1331.
The effect of the assisted zona hatching (AZH) procedure was investigated on 135 cycles with a poor prognosis of pregnancy due to: (i) maternal age > or = 38 years (45 cycles); (ii) three or more failed in-vitro fertilization (IVF) attempts (70 cycles), and (iii) patients possessing both inclusion criteria (20 cycles). The control groups (113 cycles) included patients possessing the same characteristics (42, 53 and 18 cycles respectively) and who did not undergo the AZH procedure. A total of 505 embryos was treated with AZH before transfer, resulting in: 14, 25 and 6 clinical pregnancies. The percentage of clinical pregnancies per cycle was significantly higher than controls for the first (31 vs 10% in control 1, P < 0.05) and second groups (36 vs 17% in control 2, P < 0.05). No significant difference in percentage of clinical pregnancies was found for the third group (30 vs 6%). Similarly, higher rates of implantation were obtained (11.5, 15 and 11%) compared to the respective controls (4%, P < 0.02; 6.3%, P < 0.01; and 1.5%). The rate of miscarriage in the AZH groups was similar to that obtained in the controls (22 vs 21%). Finally, the morphological analysis of the embryos transferred revealed that the poor prognosis condition is associated to a significantly slower rate of development and a higher rate of fragmentation. The present results indicate that AZH procedure improves pregnancy and implantation rates in patients with a poor prognosis of pregnancy by facilitating the hatching process in embryos which would otherwise be trapped inside the zona pellucida.
对135个因以下原因导致妊娠预后不良的周期进行了辅助孵化(AZH)程序的效果研究:(i)产妇年龄≥38岁(45个周期);(ii)三次或更多次体外受精(IVF)尝试失败(70个周期),以及(iii)符合两项纳入标准的患者(20个周期)。对照组(113个周期)包括具有相同特征(分别为42、53和18个周期)且未接受AZH程序的患者。总共505个胚胎在移植前接受了AZH处理,结果产生了14、25和6例临床妊娠。第一组(31% vs 对照组1中的10%,P<0.05)和第二组(36% vs 对照组2中的17%,P<0.05)每周期的临床妊娠百分比显著高于对照组。第三组临床妊娠百分比无显著差异(30% vs 6%)。同样,与各自对照组相比,植入率更高(分别为11.5%、15%和11%)(对照组分别为4%,P<0.02;6.3%,P<0.01;和1.5%)。AZH组的流产率与对照组相似(22% vs 21%)。最后,对移植胚胎的形态学分析表明,预后不良情况与发育速度明显减慢和碎片化率较高有关。目前的结果表明,AZH程序通过促进胚胎的孵化过程,改善了妊娠预后不良患者的妊娠率和植入率,否则这些胚胎会被困在透明带内。